3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Neoplasms
2
Brain Neoplasms
2
Sarcoma
1
Pituitary Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Hodgkin Disease
1
Glioma
1
Fatigue
1
Cytokine Release Syndrome
1
Astrocytoma
1
Interventions
Proton Therapy
2
Propofol
2
Hydrocortisone
2
Desflurane
2
parecoxib
1
loxoprofen
1
Yoga
1
Transcranial Magnetic Stimulation
1
Tramadol
1
Surgical Procedures, Operative
1
Supine Position
1
Sevoflurane
1
Saline Solution
1
Rosiglitazone
1
Resistance Training
1
Radiation Dose Hypofractionation
1
Protons
1
Positron-Emission Tomography
1
Octreotide
1
Neurosurgical Procedures
1
Neuropsychological Tests
1
Nasal Lavage
1
Human Growth Hormone
1
Endoscopic Mucosal Resection
1
Early Intervention, Educational
1
Dexamethasone
1
Deamino Arginine Vasopressin
1
Cabergoline
1
Bromocriptine
1
Bed Rest
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Pituitary Neoplasms
×
Neuropsychological Tests
×
Clear all
NCT05727605
2024-05-08
NARCiS
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
120 enrolled